This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Baxter Healthcare Sa, Baxter International Inc.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 1,205 
3 out of 2,538 
Years Active: 2025-2026
Title: Jason Robert Mantei: Pharmaceutical Formulation Inventor
Introduction
Jason Robert Mantei is an inventor associated with pharmaceutical formulations and intravenous drug-delivery systems. Based in Volo, Illinois, he is credited with 3 patents. His disclosed inventions include ready-to-use ferric carboxymaltose compositions and vasopressin premix systems.
Latest Patents
“Pharmaceutically Acceptable Ready-to-Use Ferric Carboxymaltose Compositions” describes a sealed pharmaceutical product containing a ready-to-use ferric carboxymaltose premix. The composition includes water, sodium chloride, and ferric carboxymaltose, with an iron concentration of about 2.0 to 4.0 mg of elemental iron per milliliter, preferably about 3.0 mg per milliliter. The patent describes room-temperature stability in the sealed container for at least one month.
The disclosed preparation method involves dissolving ferric carboxymaltose in water, adjusting the concentrate’s pH, applying thermal energy, and diluting the treated concentrate with sodium chloride. The resulting premix is adjusted to the specified pH, aseptically filled into a container, and sealed.
“Vasopressin Premix Systems and Uses Thereof” describes a system with a flexible container for intravenous administration that holds a premixed vasopressin pharmaceutical formulation. The invention focuses on a ready-to-administer formulation and its use in intravenous delivery.
Career Highlights
Mantei’s listed professional affiliations include Baxter International Inc. and Baxter Healthcare SA. His patent work reflects an emphasis on pharmaceutical products designed for preparation, storage, and administration.
Collaborations
His listed collaborators include Mahesh V. Chaubal and Kelly Ann Parker. Their names are associated with the patent work described above.
Conclusion
Jason Robert Mantei’s patent portfolio highlights pharmaceutical formulation and delivery innovations, including stable ferric carboxymaltose premixes and intravenous vasopressin systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile